Merck & Company (6MK) Stock Statistics & Valuation Metrics
Total Valuation
Merck & Company has a market cap or net worth of CHF 303.91B. The enterprise value is CHF 364.17B.
- Market Cap
- CHF 303.91B
- Enterprise Value
- CHF 364.17B
Share Statistics
Merck & Company has 2,467,171,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,467,171,600
- Owned by Insiders
- 0.05%
- Owned by Institutions
- 3.42%
Financial Efficiency
Merck & Company’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 18.27%.
- Return on Equity (ROE)
- 0.35
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 18.27%
- Return on Capital Employed (ROCE)
- 0.22
- Revenue Per Employee
- 877.38K
- Profits Per Employee
- 246.68K
- Employee Count
- 74,000
- Asset Turnover
- 0.47
- Inventory Turnover
- 2.73
Valuation Ratios
The current PE Ratio of Merck & Company is 152.57. Merck & Company’s PEG ratio is -1.75.
- PE Ratio
- 152.57
- PS Ratio
- 5.48
- PB Ratio
- 8.84
- Price to FCF
- 22.97
- Price to Operating Cash Flow
- 18.56
- PEG Ratio
- -1.75
Income Statement
In the last 12 months, Merck & Company had revenue of 64.93B and earned 18.25B in profits. Earnings per share was 7.30.
- Revenue
- 64.93B
- Gross Profit
- 46.73B
- Operating Income
- 23.49B
- Pretax Income
- 21.07B
- Net Income
- 18.25B
- EBITDA
- 28.26B
- Earnings Per Share (EPS)
- 7.30
Cash Flow
In the last 12 months, operating cash flow was 19.97B and capital expenditures -3.90B, giving a free cash flow of 16.06B billion.
- Operating Cash Flow
- 19.97B
- Free Cash Flow
- 16.06B
- Free Cash Flow per Share
- 6.48
Dividends & Yields
Merck & Company pays an annual dividend of ―, resulting in a dividend yield of 2.36%
- Dividend Per Share
- ―
- Dividend Yield
- 2.36%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.35%
- Earnings Yield
- 0.66%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 96.58
- 200-Day Moving Average
- 96.58
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Merck & Company upcoming earnings date is Feb 02, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- ―
Financial Position
Merck & Company as a current ratio of 1.54, with Debt / Equity ratio of 96.06%
- Current Ratio
- 1.54
- Quick Ratio
- 1.30
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- 1.27
- Interest Coverage Ratio
- 17.31
Taxes
In the past 12 months, Merck & Company has paid 2.80B in taxes.
- Income Tax
- 2.80B
- Effective Tax Rate
- 0.13
Enterprise Valuation
Merck & Company EV to EBITDA ratio is 31.91, with an EV/FCF ratio of 25.89.
- EV to Sales
- 6.18
- EV to EBITDA
- 31.91
- EV to Free Cash Flow
- 25.89
- EV to Operating Cash Flow
- 20.83
Balance Sheet
Merck & Company has CHF 7.14B in cash and marketable securities with CHF 53.91B in debt, giving a net cash position of -CHF 46.77B billion.
- Cash & Marketable Securities
- CHF 7.14B
- Total Debt
- CHF 53.91B
- Net Cash
- -CHF 46.77B
- Net Cash Per Share
- -CHF 18.95
- Tangible Book Value Per Share
- -CHF 1.85
Margins
Gross margin is 76.95%, with operating margin of 16.24%, and net profit margin of 3.64%.
- Gross Margin
- 76.95%
- Operating Margin
- 16.24%
- Pretax Margin
- 7.08%
- Net Profit Margin
- 3.64%
- EBITDA Margin
- 19.37%
- EBIT Margin
- 11.10%
Analyst Forecast
The average price target for Merck & Company is CHF 132.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- CHF 132.68
- Price Target Upside
- 37.39% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 21
- Revenue Growth Forecast
- -1.36%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 9
- AI Score
- ―